Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid TumorsAnish Thomas, Yves Pommier, Christophe E. Redon et al.|Journal of Clinical Oncology|2017Cited by 177
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung CancerNobuyuki Takahashi, Anish Thomas, Hirva Mamdani et al.|JAMA Oncology|2023Cited by 50
Abstract LB_A10: Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trialNobuyuki Takahashi, Anish Thomas, Zhonglin Hao et al.|Molecular Cancer Therapeutics|2023Cited by 0